video

Webinar: Targeting oxygen sensing in cancer

Posted: 8 January 2021 | | No comments yet

This webinar from Bio-Techne discusses canonical and alternative oxygen sensing mechanisms implicated in cancer therapy resistance and recurrence.

Bio-Techne feature image

Hypoxia is an emerging hallmark of solid tumors. It is typically transduced to the nucleus of cancer cells by HIF-dependent transcription; however, recent evidence implies that other HIF-independent pathways are activated. This webinar from Bio-Techne discusses oxygen sensing mechanisms implicated in cancer therapy resistance and recurrence, and highlights evidence suggesting conventional chemotherapy might act as an oxygen-independent HIF inducer, thus promoting therapy failure and metastasis.











    To watch this video in full, please complete the form below:

     









    This specialist content is provided to you free-of-charge thanks to the kind support of Bio-Techne

    By clicking submit you confirm that you accept our terms and conditions and privacy policy.

    Related organisations

    Send this to a friend